- 专利标题： Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
-
申请号： US13411450申请日： 2012-03-02
-
公开(公告)号： US09006237B2公开(公告)日： 2015-04-14
- 发明人: Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Giovanni Alessandro Tricarico , Grégory Louis Joseph Bar , Kim Louise Hirst , Olga Raquel Pinto Santos Oliveira Roussel , Juha Andrew Clase
- 申请人： Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Giovanni Alessandro Tricarico , Grégory Louis Joseph Bar , Kim Louise Hirst , Olga Raquel Pinto Santos Oliveira Roussel , Juha Andrew Clase
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica NV
- 当前专利权人： Janssen Pharmaceutica NV
- 当前专利权人地址： BE Beerse
- 主分类号： A61K31/503
- IPC分类号： A61K31/503 ; A61K31/4985 ; C07D403/12 ; C07D407/04 ; C07D487/04
摘要：
Novel fused pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammation, rheumatoid arthritis and others.
公开/授权文献
信息查询
IPC分类:
